3557 results for «217»
3557 results
Intracoronary imaging to guide management in ACS
16 May 2024 – From EuroPCR 2024
This session focuses on the role of intracoronary imaging, specifically IVUS and OCT, in the management of Acute Coronary Syndrome (ACS). Participants will learn when intracoronary imaging can facilitate diagnosis and guide PCI, as well as discuss image interpretation in the setting of ACS.
Devices in pulmonary embolism - Why you should be interested!
15 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...
Management of patient with coronary artery disease and left ventricle dysfunction
15 May 2024 – From EuroPCR 2024
This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...
Nightmare cases
15 May 2024 – From EuroPCR 2024
Antiplatelet de-escalation after complex PCI: when and how?
15 May 2024 – From EuroPCR 2024
Acute and chronic right ventricular failure: focus on the weak link
16 May 2024 – From EuroPCR 2024
This session discusses new diagnostic and therapeutic aspects of shock due to right ventricular infarction, explores why and how the failing right ventricle contributes to worsening heart failure, and examines device-based treatment opportunities for chronic right ventricular and tricuspid valve failure, including repair vs replacement. It...
PCI of bifurcation lesions: management of complications - Part 1
16 May 2024 – From EuroPCR 2024
Explore strategies for managing complex PCI of bifurcation lesions through case discussions. From stent deformation and delicate diagonal wiring to wire fracture with snare failure, decoiled coronary guidewires, misplaced stents, spontaneous coronary artery dissection, and late tamponade after PCI, this session covers how to effectively respond...
From machine learning to redo-TAVR: Pioneering abstracts unveiled
16 May 2024 – From EuroPCR 2024
This session features selected abstract submissions from EuroPCR 2024, showcasing the latest innovations and research in interventional cardiology. The presenters will have the opportunity to share their work and receive feedback from the audience, fostering collaboration and the exchange of ideas within the interventional cardiology community.
First results of randomised trials on advanced plaque modification techniques and intracoronary imaging
16 May 2024 – From EuroPCR 2024
This session presents the first results of randomized trials investigating the use of advanced plaque modification techniques, such as rotational atherectomy, lithotripsy, and laser atherectomy, as well as the role of intracoronary imaging (OCT and IVUS) in guiding percutaneous coronary intervention (PCI). The session aims to...
Mitral and tricuspid hotline
16 May 2024 – From EuroPCR 2024
This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
Imaging and physiology guided PCI
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 clinical case submissions showcasing the use of imaging and physiology guidance during PCI. Cases cover topics such as managing cardiac arrest during PCI, virtual reality-guided PCI, low-contrast PCI in multivessel disease, and the comprehensive assessment of obstructive and non-obstructive coronary...
Management of PCI complications - Part 1
16 May 2024 – From EuroPCR 2024
This session comprises a series of selected EuroPCR 2024 Clinical Case submissions, focusing on the management of various PCI complications. Participants will explore cases involving coronary physiology challenges, iatrogenic compressive coronary intramural hematoma, misbehaving stents, catheter-induced dissections, and device malfunctions, along with the corresponding bailout techniques...
POPular TAVI - Antithrombotic Therapy After Transcatheter Aortic Valve Implantation in Patients With a Long-Term Indication for Oral Anticoagulation
04 Apr 2020
The POPular TAVI trial is an open label randomized study designed to evaluate oral anticoagulation (OAC) alone compared with OAC plus clopidogrel for 3 months in patients undergoing transcatheter aortic valve replacement (TAVR) with a long-term indication for oral anticoagulation. Those who had undergone percutaneous revascularization...
Author
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona
Author
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578
Author
EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES
14 May 2024
